Circulating tumor-derived DNA is shorter than somatic DNA in plasma
Year: 2015
Type: article
Abstract: Circulating tumor DNA (ctDNA) is now widely investigated as a biomarker in translational and clinical research (1). However, despite the growing field of clinical applications, the biology of ctDNA remains unclear. In trying to learn about the origins of ctDNA, nature provides us with very few clues. One of the important accessible parameters is the size of those DNA fragments. In addition, a well-informed model of these sizes and biases can help design more efficient and accurate diagnostic methods. In PNAS, Jiang et al. take an important step in that direction (2).
Authors: Florent Mouliere, Nitzan Rosenfeld
Institutions: University of Cambridge, Cancer Research UK
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
Funder: Cancer Research UK
Award: G4797612234
OpenAlex ID: W2033756944
